Loading...
•
Jun 29, 2024
Rayonier AM Q2 2024 Earnings Report
Reported strong financial results driven by improved product mix and cost management.
Key Takeaways
Rayonier Advanced Materials reported net sales of $419 million for the second quarter of 2024, a $34 million increase from the prior year quarter. Income from continuing operations was $8 million, up $24 million from the prior year quarter, and adjusted EBITDA from continuing operations was $68 million, up $41 million from the prior year quarter. The company increased its 2024 Adjusted EBITDA guidance to $205 million to $215 million and Adjusted Free Cash Flow guidance to $100 million to $110 million.
Net sales increased by $34 million to $419 million compared to the prior year quarter.
Income from continuing operations increased by $24 million to $8 million compared to the prior year quarter.
Adjusted EBITDA increased by $41 million to $68 million compared to the prior year quarter, including $10 million of CEWS benefits.
Adjusted Free Cash Flow was $69 million.
Revenue by Segment
Forward Guidance
The Company is actively pursuing the refinancing of its 2026 Senior Notes before they go current in January 2025 and strongly believes that, due to improving business performance and credit metrics, it will secure refinancing at satisfactory terms. The Company expects to generate between $205 million and $215 million of Adjusted EBITDA in 2024 with $100 million to $110 million of Adjusted Free Cash Flow, including passive asset sales but excluding any operating asset sales.
Positive Outlook
- Average sales prices for cellulose specialties in 2024 are expected to increase by a low single-digit percentage as compared to average sales prices in 2023 as the Company continues to prioritize value over volume.
- Sales volumes for cellulose specialties are expected to increase compared to 2023 driven by increased volumes from the closure of a competitor’s plant, a modest increase in ethers sales and additional volume sold to customers ahead of the suspension of Temiscaming HPC operations, partially offset by a one-time favorable impact from a change in customer contract terms in the prior year first quarter and customer destocking in the acetate markets.
- Demand for RYAM commodity products remains stable.
- Commodity sales volumes are expected to increase slightly in the second half of 2024 due to increased fluff sales.
- The Company’s bioethanol facility in Tartas, France is operating as expected and represents a significant milestone towards the Company’s goal of generating $42 million of annual EBITDA from these biomaterial products in 2027.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...